
Sign up to save your podcasts
Or
Low anticoagulant adherence in atrial fib cost DOAC users more than warfarin users in thromboembolic events. The USPSTF says additional ECGs in asymptomatic, low-risk adults don’t do any good. Can C-reactive protein apheresis reduce post-MI infarct size?
4.9
1616 ratings
Low anticoagulant adherence in atrial fib cost DOAC users more than warfarin users in thromboembolic events. The USPSTF says additional ECGs in asymptomatic, low-risk adults don’t do any good. Can C-reactive protein apheresis reduce post-MI infarct size?